Singh N - Search Results

1

Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate.

Jones NS, Winter H, Katsumoto TR, Florero M, Murray E, Walker H, Singh N, Chinn LW. Jones NS, et al. Among authors: singh n. J Pharmacol Exp Ther. 2019 Oct;371(1):202-207. doi: 10.1124/jpet.119.257089. Epub 2019 Aug 1. J Pharmacol Exp Ther. 2019. PMID: 31371481 Clinical Trial.

2

Absorption, metabolism and excretion of opicapone in human healthy volunteers.

Loureiro AI, Rocha F, Santos AT, Singh N, Bonifácio MJ, Pinto R, Kiss LE, Soares-da-Silva P. Loureiro AI, et al. Among authors: singh n. Br J Clin Pharmacol. 2022 Oct;88(10):4540-4551. doi: 10.1111/bcp.15383. Epub 2022 May 20. Br J Clin Pharmacol. 2022. PMID: 35508762 Free PMC article.

3

Development of AITC-induced dermal blood flow as a translational in vivo biomarker of TRPA1 activity in human and rodent skin.

Joseph V, Yang X, Gao SS, Elstrott J, Weimer RM, Theess W, Thrasher C, Singh N, Lin J, Bauer RN. Joseph V, et al. Among authors: singh n. Br J Clin Pharmacol. 2021 Jan;87(1):129-139. doi: 10.1111/bcp.14370. Epub 2020 Jun 2. Br J Clin Pharmacol. 2021. PMID: 32415670 Free article.

4

A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors.

Schueller O, Willson A, Singh N, Lohmer L, Alabanza A, Patel J. Schueller O, et al. Among authors: singh n. Clin Pharmacol Drug Dev. 2022 Jul;11(7):795-806. doi: 10.1002/cpdd.1082. Epub 2022 Mar 1. Clin Pharmacol Drug Dev. 2022. PMID: 35230741 Clinical Trial.

5

Evaluation of the drug disposition of RO7049389 with in vitro data and human mass balance supported by physiologically based pharmacokinetic modelling.

Zhang Y, Umehara K, Romeo AA, Singh N, Cantrill C, Savage M, Chen E, Zhang W, Parrot NJ, Paehler A. Zhang Y, et al. Among authors: singh n. Br J Clin Pharmacol. 2023 Oct;89(10):3079-3091. doi: 10.1111/bcp.15809. Epub 2023 Jun 20. Br J Clin Pharmacol. 2023. PMID: 37264516

6

Two-Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants.

Schueller O, Regev G, Singh N, Willson A, Beville M, Kanji N, Lohmer L, Patel J. Schueller O, et al. Among authors: singh n. Clin Pharmacol Drug Dev. 2024 May;13(5):491-498. doi: 10.1002/cpdd.1378. Epub 2024 Feb 12. Clin Pharmacol Drug Dev. 2024. PMID: 38345529 Clinical Trial.

7

Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [¹⁴ C]-Belumosudil in Healthy Men: A Phase 1, Open-Label, 2-Part Study.

Schueller O, Skucas E, Regev G, Shaw I, Singh N, Sanghvi M, Croft M, Lohmer L, Alabanza A, Patel J. Schueller O, et al. Among authors: singh n. Clin Pharmacol Drug Dev. 2022 Jul;11(7):786-794. doi: 10.1002/cpdd.1085. Epub 2022 Mar 1. Clin Pharmacol Drug Dev. 2022. PMID: 35231159 Clinical Trial.

8

Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial.

Bala F, Singh N, Ignacio K, Alhabli I, Ademola A, Alrohimi A, Khosravani H, Tkach A, Catanese L, Dowlatshahi D, Field T, Hunter G, Benali F, Horn M, Demchuk A, Hill M, Sajobi T, Buck B, Swartz R, Almekhlafi M, Menon BK. Bala F, et al. Among authors: singh n. J Stroke. 2024 May;26(2):280-289. doi: 10.5853/jos.2023.03713. Epub 2024 May 30. J Stroke. 2024. PMID: 38836275

9

Medical, Administrative, Financial, and Social Challenges in the Management of a Case of Hemolytic Disease of the Fetus Caused by a Rare Alloantibody in a Low-Resource Setting.

Sharma KA, Pandey H, Singh N, Garg D, P S, Dadhwal V, Rana A, Chaudhary P. Sharma KA, et al. Among authors: singh n. Cureus. 2024 May 5;16(5):e59676. doi: 10.7759/cureus.59676. eCollection 2024 May. Cureus. 2024. PMID: 38836139 Free PMC article.

10

In silico predicted compound targeting the IQGAP1-GRD domain selectively inhibits growth of human acute myeloid leukemia.

Sahasrabudhe DM, Liesveld JL, Minhajuddin M, Singh NA, Nath S, Kumar VM, Balys M, Evans AG, Azadniv M, Hansen JN, Becker MW, Sharon A, Thomas VK, Moore RG, Khera MK, Jordan CT, Singh RK. Sahasrabudhe DM, et al. Among authors: singh na. Sci Rep. 2024 Jun 4;14(1):12868. doi: 10.1038/s41598-024-63392-2. Sci Rep. 2024. PMID: 38834690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,098 results

Search Page